MARCH/APRIL 2001

Vol 8, No 2 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours. CME is presented by an unrestricted educational grant from Bristol-Myers Squibb Oncology Division.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• understand the significance of prostate-specific antigen (PSA)-based screening,
• recognize the value of trans rectal ultrasound in the diagnosis of prostate cancer,
• describe the approaches to management of prostate cancer, including observation, and
• recognize the importance of infections in cutaneous T-cell lymphoma.

This program was planned in accordance with ACCME Essentials.

Release Date: March 1, 2001
Expiration Date: March 1, 2002

1. The best screening method for prostate cancer in asymptomatic men is:

a. transrectal ultrasound (TRUS)
b. digital rectal examination (DRE)
c. PSA plus DRE
d. PSA

2. Which of the following is not an expected problem with long-term hormonal deprivation for prostate cancer?

a. anemia
b. thromboembolism
c. decreased libido
d. hot flashes

3. What was the incidence of grade 1 prostate cancers in the series of patients reported by Chodak et al who were managed by observation?

a. 7%
b. 16%
c. 32%
d. 59%